Scinai Immunotherapeutics (SCNI) said Tuesday that it signed a $2 million investment commitment agreement with RK Stone Miami, an affiliate of its largest shareholder Daniel Stone.
The company said the deal allows it to sell American depositary shares totaling $2 million to the investor from time to time through the end of this year, under certain conditions.
Scinai shares were more than 4% higher in recent trading.
Price: 4.30, Change: +0.28, Percent Change: +6.97
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments